Cargando…
Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment
BACKGROUND: Rituximab has been widely used in many autoimmune diseases. AIM: To evaluate the infection risk of rituximab in autoimmune hematological disorders. METHODS: Retrospectively studied and compared the clinical data of 89 patients in our hospital who used low‐dose rituximab (group R) or puls...
Autores principales: | Wang, Honglei, Yan, Siyang, Liu, Hui, Li, Lijuan, Song, Jia, Wang, Guojin, Wang, Huaquan, Wu, Yuhong, Shao, Zonghong, Fu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595891/ https://www.ncbi.nlm.nih.gov/pubmed/32794271 http://dx.doi.org/10.1002/jcla.23455 |
Ejemplares similares
-
Characteristics of patients with autoimmune haemolytic anaemia secondary to lymphoproliferative disorder: A single-centre retrospective analysis
por: Xing, Limin, et al.
Publicado: (2019) -
Clinical observation of low‐dose combination chemotherapy in refractory/recurrent paroxysmal nocturnal hemoglobinuria patients: A single‐center retrospective analysis
por: Li, Liyan, et al.
Publicado: (2022) -
Pseudo-monoclonal gammopathy due to autoimmune disease: a case
report
por: Liu, Hui, et al.
Publicado: (2019) -
Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease
por: Fu, Rong, et al.
Publicado: (2014) -
Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function
por: Chen, Jin, et al.
Publicado: (2019)